BARD1 soars on cancer tech update

15/02/2021 - 15:30

Bookmark

Save articles for future reference.

Shares in BARD1 Life Sciences have more than doubled, after the diagnostics business revealed its SubB2M technology can be used to detect all stages of breast cancer.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options